Cc5013 - PharmaKB

Cc5013

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

1319 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Multiple myeloma	D009101	—	C90.0	166	330	132	16	59	619
Plasma cell neoplasms	D054219	—	—	105	178	55	10	44	339
Lymphoma	D008223	—	C85.9	68	135	13	3	23	204
Follicular lymphoma	D008224	—	C82	37	54	20	1	3	93
B-cell lymphoma	D016393	—	—	29	54	5	1	9	81
Myelodysplastic syndromes	D009190	—	D46	26	41	4	1	10	74
Neoplasms	D009369	—	C80	29	18	4	1	2	44
Myeloid leukemia acute	D015470	—	C92.0	22	20	1	1	3	41
T-cell lymphoma peripheral	D016411	—	—	14	19	—	2	2	30
T-cell lymphoma	D016399	—	—	11	19	—	1	3	28

Show 12 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Large b-cell lymphoma diffuse	D016403	—	C83.3	40	82	13	—	13	123
Leukemia	D007938	—	C95	42	70	4	—	4	104
B-cell chronic lymphocytic leukemia	D015451	—	C91.1	42	61	4	—	2	91
Non-hodgkin lymphoma	D008228	—	C85.9	41	52	6	—	5	80
Recurrence	D012008	—	—	30	35	12	—	2	66
Mantle-cell lymphoma	D020522	—	C83.1	30	37	4	—	4	61
Lymphoid leukemia	D007945	—	C91	20	36	3	—	3	54
Preleukemia	D011289	—	—	18	30	3	—	7	53
Syndrome	D013577	—	—	16	32	2	—	7	52
B-cell lymphoma marginal zone	D018442	—	C88.4	25	27	7	—	2	48

Show 28 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Waldenstrom macroglobulinemia	D008258	—	C88.0	14	11	—	—	—	19
Hodgkin disease	D006689	—	C81	13	10	—	—	—	18
Burkitt lymphoma	D002051	—	C83.7	11	7	—	—	1	14
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	C91.0	7	6	—	—	1	12
T-cell lymphoma cutaneous	D016410	—	C84.A	7	5	—	—	—	11
Large-cell lymphoma anaplastic	D017728	—	C84.6	8	7	—	—	—	10
Adult t-cell leukemia-lymphoma	D015459	—	C91.5	6	4	—	—	—	9
Immunoblastic lymphadenopathy	D007119	EFO_1001350	C86.5	5	5	—	—	1	9
Sezary syndrome	D012751	—	C84.1	5	5	—	—	—	8
Mycosis fungoides	D009182	—	C84.0	5	5	—	—	—	8

Show 128 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Neuroblastoma	D009447	EFO_0000621	—	3	—	—	—	—	3
Colonic neoplasms	D003110	—	C18	2	—	—	—	—	2
Rectal neoplasms	D012004	—	—	2	—	—	—	—	2
Nervous system neoplasms	D009423	—	—	2	—	—	—	—	2
Disease	D004194	EFO_0000408	R69	2	—	—	—	—	2
Promyelocytic leukemia acute	D015473	—	C92.4	2	—	—	—	—	2
Plasmablastic lymphoma	D000069293	—	C83.3	2	—	—	—	—	2
Mediastinal neoplasms	D008479	—	C38.3	1	—	—	—	—	1
Urethral neoplasms	D014523	EFO_0003846	—	1	—	—	—	—	1
Ureteral neoplasms	D014516	EFO_0003844	C66	1	—	—	—	—	1

Show 41 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Abnormal karyotype	D059786	—	—	—	—	—	—	1	1
Patient compliance	D010349	—	—	—	—	—	—	1	1
Medication adherence	D055118	EFO_0006344	—	—	—	—	—	1	1
Patient satisfaction	D017060	—	—	—	—	—	—	1	1
Personal satisfaction	D010549	—	—	—	—	—	—	1	1
Patient preference	D057240	—	—	—	—	—	—	1	1
Progression-free survival	D000077982	—	—	—	—	—	—	1	1
Dermatomyositis	D003882	EFO_0000398	M33	—	—	—	—	1	1
Oral ulcer	D019226	—	—	—	—	—	—	1	1
Sars-cov-2	D000086402	—	—	—	—	—	—	1	1

Show 4 more

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	—
INN	—
Description	—
Classification	Unknown
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	—